Yang M - Search Results

1

Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.

Kimball AB, Delevry D, Yang M, Chuang CC, Wang Z, Bégo-Le-Bagousse G, Martins B, Wu E, Shumel B, Wang J, Sierka D, Chao J, Strober B. Kimball AB, et al. Among authors: yang m. Dermatol Ther (Heidelb). 2023 Sep;13(9):2107-2120. doi: 10.1007/s13555-023-00965-5. Epub 2023 Aug 8. Dermatol Ther (Heidelb). 2023. PMID: 37552431 Free PMC article.

2

Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.

Kimball AB, Jemec GB, Yang M, Kageleiry A, Signorovitch JE, Okun MM, Gu Y, Wang K, Mulani P, Sundaram M. Kimball AB, et al. Among authors: yang m. Br J Dermatol. 2014 Dec;171(6):1434-42. doi: 10.1111/bjd.13270. Epub 2014 Nov 11. Br J Dermatol. 2014. PMID: 25040429 Clinical Trial.

3

Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review.

Liu Y, Yang M, Garg V, Wu EQ, Wang J, Skup M. Liu Y, et al. Among authors: yang m. Adv Ther. 2019 Aug;36(8):1851-1877. doi: 10.1007/s12325-019-00998-3. Epub 2019 Jun 5. Adv Ther. 2019. PMID: 31168766 Free PMC article.

4

Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus Infections.

Welzel TM, Yang M, Sajeev G, Chen YJ, Pinsky B, Bao Y, Wu EQ, Dieterich D. Welzel TM, et al. Among authors: yang m. Adv Ther. 2019 Sep;36(9):2475-2486. doi: 10.1007/s12325-019-01012-6. Epub 2019 Jun 25. Adv Ther. 2019. PMID: 31240629 Free PMC article.

5

Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis.

Simpson E, Eckert L, Gadkari A, Mallya UG, Yang M, Nelson L, Brown M, Reaney M, Mahajan P, Guillemin I, Boguniewicz M, Pariser D. Simpson E, et al. Among authors: yang m. BMC Dermatol. 2019 Nov 6;19(1):15. doi: 10.1186/s12895-019-0095-3. BMC Dermatol. 2019. PMID: 31690295 Free PMC article.

6

Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis: The UltIMMa-1 and UltIMMa-2 Randomized Clinical Trials.

Augustin M, Lambert J, Zema C, Thompson EHZ, Yang M, Wu EQ, Garcia-Horton V, Geng Z, Valdes JM, Joshi A, Gordon KB. Augustin M, et al. Among authors: yang m. JAMA Dermatol. 2020 Dec 1;156(12):1344-1353. doi: 10.1001/jamadermatol.2020.3617. JAMA Dermatol. 2020. PMID: 33052382 Free PMC article. Clinical Trial.

7

Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis: 1-Year Results From the RELIEVE-AD Study.

Strober B, Mallya UG, Yang M, Ganguli S, Gadkari A, Wang J, Sierka D, Delevry D, Kimball AB. Strober B, et al. Among authors: yang m. JAMA Dermatol. 2022 Feb 1;158(2):142-150. doi: 10.1001/jamadermatol.2021.4778. JAMA Dermatol. 2022. PMID: 34910086

8

The impact of achieving and maintaining near-complete or complete skin clearance on patient quality of life in moderate-to-severe psoriasis.

Ryan C, Puig L, Zema C, Thompson EHZ, Yang M, Wu E, Bensimon A, Huang X, Joshi AD, Elewski B. Ryan C, et al. Among authors: yang m. J Am Acad Dermatol. 2023 Jan;88(1):169-172. doi: 10.1016/j.jaad.2021.12.032. Epub 2021 Dec 24. J Am Acad Dermatol. 2023. PMID: 34954285 No abstract available.

9

Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018.

Liu Y, Skup M, Yang M, Qi CZ, Wu EQ. Liu Y, et al. Among authors: yang m. Adv Ther. 2022 Aug;39(8):3711-3734. doi: 10.1007/s12325-022-02173-7. Epub 2022 Jun 23. Adv Ther. 2022. PMID: 35737227 Free PMC article.

10

Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018.

Liu Y, Skup M, Yang M, Qi CZ, Wu EQ. Liu Y, et al. Among authors: yang m. Adv Ther. 2022 Nov;39(11):5300. doi: 10.1007/s12325-022-02255-6. Adv Ther. 2022. PMID: 36040636 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29,410 results

Search Page